Journal of Evidence-Based Medicine
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 4.7 | Q1 | 86.3% | 0.977 | Q1 | 83.3% |
| 2024 | 3.5 | Q1 | 84.4% | 1.021 | Q1 | 84.8% |
| 2023 | 3.6 | Q1 | 87.8% | 1.213 | Q1 | 89.5% |
| 2022 | 7.3 | Q1 | 91.5% | 1.070 | Q1 | 87.8% |
| 2021 | 6.2 | Q1 | 90.3% | 0.911 | Q1 | 84.5% |
| 2020 | — | — | 0.885 | Q1 | 82.4% | |
| 2019 | — | — | 0.662 | Q2 | 75.5% | |
| 2018 | — | — | 1.093 | Q1 | 86.1% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1756-5383
ISSN
1756-5391
country
UScoverage
2008-2026